Patrick Blaney, MS1,2*, Brian A. Walker, PhD3, Aneta Mikulasova, PhD4*, Dylan Gagler, B.S.1,2*, Bachisio Ziccheddu5*, Benjamin Diamond, M.D.5*, Yubao Wang, PhD1*, Liming Hou, PhD1*, Sanxiong Liu, PhD1*, Alexandra Maria Poos, PhD6*, Anthony Cirrincione, PhD5*, Kylee H Maclachlan, MBChB, PhD7, Elias K. Mai, M.D.6*, Hartmut Goldschmidt6, Saad Z Usmani, MD8, Marc S. Raab6*, Niels Weinhold, PhD6*, Ola Landgren, MD5, Faith E. Davies, MD1, Francesco Maura, MD9 and Gareth J. Morgan, M.D., Ph.D.1*
1Perlmutter Cancer Center, Multiple Myeloma Research Program, NYU Grossman School of Medicine, NYU Langone Health, New York, NY
2Applied Bioinformatics Laboratories, NYU Grossman School of Medicine, NYU Langone Health, New York, NY
3Simon Comprehensive Cancer Center, Division of Hematology Oncology, Indiana University School of Medicine, Indianapolis, IN
4Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom
5Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL
6Heidelberg Myeloma Center, Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
7Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
9Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, PALMETTO BAY, FL